# Vitalant – FDA Inspection, Jan 10, 2025

Source: https://www.keypedia.com/records/fda_inspections/vitalant/245fd1f8-ee1c-4c17-8cb2-654f0d7df0e2
Source feed: FDA_Inspections

> FDA inspection 1258280 of Vitalant, January 10, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1258280
- Company Name: Vitalant
- Inspection Date: 2025-01-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: San Francisco District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1095038 - 2019-06-12
- FDA Inspection 1017575 - 2017-06-29
- FDA Inspection 918958 - 2015-03-19
- FDA Inspection 829294 - 2013-04-26
- FDA Inspection 732726 - 2011-06-29

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/conor-j-mccarron/280401e4-b080-4ba8-ab35-d3b16e91c2b1)

Company: https://www.keypedia.com/companies/vitalant/1c3fd7ce-e521-452c-a183-9d6e73cd1ac1

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df
